An interventional study of Modified constraint-induced movement therapy and Conventional physical therapy in Spastic Hemiplegic Cerebral Palsy, sponsored by Cairo University. Recruiting at 1 site in Egypt. Open to participants aged 6 Years to 8 Years. Per ClinicalTrials.gov, last updated 2026-07-07.
Sponsored by Cairo University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 114 studies in Cerebral Palsy by Cairo University — 28 open to participants now, 34 under way, 1 of them phase 3. Cerebral Palsy · Cairo University.
Among the 114 studies in Cerebral Palsy by Cairo University, this one is the 68th largest by planned enrollment of the 94 interventional ones that give a count, is one of 18 that started in 2026, is one of 93 with no phase, reaches primary completion later than 21 of the 33 other live ones, and was the 103rd registered.
1,942 studies on the registry are indexed under Cerebral Palsy; 456 are open to participants now.
Browse Cerebral Palsy studies →28 of the 114 studies in Cerebral Palsy by Cairo University are open now, in 1 country. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18–45 · Women only
Cairo University · Sites in Egypt
Ages 5–7
Cairo University · Sites in Egypt
Ages 4–7
Cairo University · Sites in Egypt
Ages 8–12
Cairo University · Sites in Egypt
Ages 8–12
By country, each count listing its studies:
Of the 271 Cerebral Palsy studies recruiting now, 26 (10%) set no upper age limit and 237 (87%) stop at 75 or younger; 256 take children under 18; 53 take healthy volunteers.
This study: 6 Years to 8 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
114 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 18 started in 2026.
This study's planned enrollment of 30 is below the median of 34 across 1,434 interventional studies indexed under Cerebral Palsy.
Median enrollment 40 across the 94 interventional studies, 60 across the 20 observational. Of the 65 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Cairo University is the lead sponsor of 4,967 studies on the registry; 1,474 are open to participants now.
Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.
5 of the studies in Cerebral Palsy by Cairo University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07725627Cairo UniversityEffect of Q Angle and BMI on Dynamic Balance in Spastic Diplegic Children | 2026-12-01 |
| NCT07818616Cairo UniversityElectromyography Biofeedback Training Versus Mirror Therapy on Muscle Activity, Range of Motion and Function of Upper Limb in Children With Hemiplegia | 2026-12-15 |
| NCT07595744Cairo UniversitySensory Walkway and Gait in Children With Diplegic Cerebral Palsy | 2026-12-30 |
| NCT07748052Cairo UniversityStrength Training Combined With Blood Flow Restriction and Cerebral Palsy | 2027-02-01 |
| NCT07907497Cairo UniversityEffect of Robotic Gloves Training on Upper Limb Coordination, Selective Motor Control and Activities of Daily Living in Children With Hemiparetic Cerebral Palsy | 2027-03-01 |
Add all 5 to your calendar (.ics) → With an account.
Among the 114 studies in Cerebral Palsy by Cairo University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Children with spastic hemiplegic cerebral palsy experience longer gait cycles, slower walking speeds, and longer support phases compared to healthy children, with substantial joint angle differences noted during ground contact and stride buffering. Although most can achieve independent walking, they often exhibit poor motor coordination, resulting in short strides and high stride frequencies for speed maintenance. Modified constraint-induced movement therapy has been employed to enhance lower-extremity function, but its effectiveness on key ambulation aspects like gait speed and balance remains unclear. The reliance on the unaffected limb further impacts locomotive behavior, leading to stiff knee gait and reduced functional mobility. This study aims to explore the therapy's effects on locomotion in hemiplegic children.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Fifteen children will receive a conventional physical therapy program for 1 hour and modified constraint-induced movement therapy for 30 minutes 3 times per week for 4 weeks.
Other: Modified constraint-induced movement therapy · Other: Conventional physical therapy
Fifteen children will receive conventional physical therapy program only for 1 hour 3 times per week for 4 weeks.
Other: Conventional physical therapy
Three tasks will be designed to be performed for 10 min each while using the knee scooter as a method of constraint-induced movement therapy The 3 tasks will be as follows: 1. Walking with knee scooter forward on 8 meter walkway 2. Walking with knee scooter backward on 8 meter walkway 3. Standing with the knee scooter on balance board
1. Repetitive motor training following shaping task * Step on stool. * Squat to stand. * Pressing the pedal stepper. * Walking on treadmill. * Bicycle. * Air walker. 2. Behavioral strategies: * Walking with picking toys from ground * Passing obstacles * Walking with a ball, moving it by the lower extremity
assessment of spatial gait parameters
Kinovea is a free 2D motion analysis software that facilitates inexpensive, sensor-free video-based motion assessments suitable for clinical practice. Its reliability has been established for measuring cervical range of motion (ROM) in both sagittal and frontal planes, dominant wrist joint ROM, shoulder ROM, and ankle joint ROM during walking. Additionally, it effectively measures spatial gait parameters, including stride length, step length, and hip, knee, and ankle angles at initial contact and mid-swing stages of the gait cycle. Required tools for its use include a walking area, digital camera, adhesive skin marks, and a tripod.
Time frame: At baseline and after Four weeks
assessment of Temporal gait parameters
Kinovea is a free 2D motion analysis software that utilizes inexpensive, sensor-free video-based techniques for clinical motion analysis. Its reliability is essential for assessing important psychometric properties, especially in measuring various range of motion (ROM) for cervical, shoulder, and ankle joints, as well as capturing gait parameters like stance and swing phases. Required tools for its use include a walking area, digital camera, adhesive skin marks, and a tripod.
Time frame: At baseline and after four weeks
assessment of the functional mobility
The Gross Motor Function Measure (GMFM-88) is a reliable and valid assessment tool for measuring gross motor function in children with cerebral palsy, specifically focusing on standing (segment D) and walking/running (segment E). It is widely used in clinical and research settings to track changes over time or assess the impact of interventions. Due to its lengthy administration time, it is best used for annual or biannual evaluations or research studies, and testers should be well-versed in its use prior to administration.
Time frame: At baseline and after four weeks
Started Jun 2026 (actual). Primary completion is estimated for Jul 2026, 1 month after the start.
Of 906 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 1 month is below that.
Counting every sponsor, half of 925 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.